Q2 2023 13F Holders as of 6/30/2023
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
57.9M
-
Number of holders
-
134
-
Total 13F shares, excl. options
-
48.1M
-
Shares change
-
+2.5M
-
Total reported value, excl. options
-
$1.52B
-
Value change
-
+$79.5M
-
Put/Call ratio
-
0.13
-
Number of buys
-
99
-
Number of sells
-
-40
-
Price
-
$31.62
Significant Holders of Arcellx, Inc. - COMMON STOCK (ACLX) as of Q2 2023
150 filings reported holding ACLX - Arcellx, Inc. - COMMON STOCK as of Q2 2023.
Arcellx, Inc. - COMMON STOCK (ACLX) has 134 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 48.1M shares
of 57.9M outstanding shares and own 83.08% of the company stock.
Largest 10 shareholders include FMR LLC (4.69M shares), PERCEPTIVE ADVISORS LLC (4.02M shares), SR ONE CAPITAL MANAGEMENT, LP (3.95M shares), NEA Management Company, LLC (3.75M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (2.85M shares), BlackRock Inc. (2.6M shares), Paradigm Biocapital Advisors LP (2.35M shares), Cormorant Asset Management, LP (2M shares), VANGUARD GROUP INC (1.99M shares), and STATE STREET CORP (1.93M shares).
This table shows the top 134 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.